Appeal No. 96-0419
Application No. 07/928,063
of claims 1, 3, 4 and 7 through 10 under 35 U.S.C. § 103 as unpatentable over Amari in view of
Merck is reversed.
C. Rejection of claims 1, 3, 4, 9 and 10 under 35 U.S.C. § 103 as unpatentable over Miki or
Isobe.
Miki discloses a deodorant composition comprising an acidic phosphoric compound, a copper
compound and a reducing agent (col. 1, lines 29-35). The copper compound may be sodium copper
chlorophyllin or potassium copper chlorophyllin, singly or in combination, usually present in 0.001 to
200 parts by weight per 100 parts by weight of the phosphoric acid compound (col. 2, lines 14-33 and
63-66). The reducing agent may be sodium sulfite or sodium thiosulfate and is usually present in 0.001
to 50 parts by weight per 100 parts by weight of the phosphoric acid compound (col. 2, lines 43-53;
col. 3, lines 2-6).
Isobe discloses an adhesive composition comprising a (meth)acrylate monomer, a
polymerization initiator, and an additive, such as chlorophyll, metal-substituted chlorophyll or
chlorophyllin salt (col. 2, lines 43-53; col. 3, lines 2-6). The polymerization initiator may be a
combination of an organic peroxide and a reducing agent, such as diacylperoxide and thioglycolic acid
(col. 4, line 63 - col. 5, line 25). The reducing agent is present at 0.1-5 parts by weight, preferably
0.3-2 parts by weight, per 100 parts by weight of the (meth)acrylate monomer (col. 5, lines 41-43).
Sodium copper chlorophyllin is a preferred additive compound because of its high stability (col. 6, lines
7
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007